dihexa cognitive enhancement studies 2019 2024 Alzheimer's disease drug development pipeline: - Cummings - 2024 Age against the machine—susceptibility of
Age against the machinesusceptibility of large language models to cognitive impairment: cross sectional analysis The BMJ Pathway based network medicine identifies novel natural products for Alzheimer's disease Alzheimer's Research & Therapy Springer Nature Link The 2024 Alzheimer's disease drug development pipeline report is out Alzheimer Europe Frontiers The rising use of cognitive enhancement drugs and predictors of use during COVID 19: findings from a cross sectional survey of students and university staff in the UK
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


